Australia, July 18 -- Australia based Takeda Pharmaceuticals Australia Pty Ltd has secured contract from National Blood Authority for Procurement of Imported Plasma and Recombinant Products (IPRP) - Adynovate. The value of the contract is worth 22,323,957.70 AUD.
Published by HT Digital Content Services with permission from Pivotal Sources....